Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-03-26 @ 10:15 PM
Study NCT ID:
NCT00903851
Status:
COMPLETED
Last Update Posted:
2010-02-15
First Post:
2009-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy
Sponsor:
Endo Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EN3220-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sr. Director, Clinical R&D
Old Organization:
Endo Pharmaceuticals Inc.